Corrigendum to “APOA5 Variants Predispose Hyperlipidemic Patients to Atherogenic Dyslipidemia and Subclinical Atherosclerosis” [Atherosclerosis 240/1 (2015) 98–104]

Atherosclerosis - Netherlands
doi 10.1016/j.atherosclerosis.2016.05.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Subclinical Atherosclerosis

2005English

High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation

Metabolic Syndrome and Related Disorders
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Chronic Kidney Disease, Dyslipidemia, and Atherosclerosis

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2012English

Atherogenic Lipoprotein Particles in Atherosclerosis

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Biomarkers of Subclinical Atherosclerosis in Patients With Psoriatic Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2019English

Zebrafish Models for Dyslipidemia and Atherosclerosis Research

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2016English

Effect of standardizedAmlaextract on Atherosclerosis and Dyslipidemia

Indian Journal of Pharmaceutical Sciences
Pharmaceutical Science
2006English

Linking Cardiorespiratory Fitness Classification Criteria to Early Subclinical Atherosclerosis in Children

Applied Physiology, Nutrition and Metabolism
NutritionEndocrinologySports SciencePhysiologyDieteticsMedicineMetabolismDiabetes
2015English

Circulating Vitamin D Metabolites and Subclinical Atherosclerosis in Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy